Thomson Scientific Adds EMBASE Classic to Dialog And DataStar
More than 25 Years of Archived Biomedical and Pharmacological Records
Accessible in Electronic Format for the First Time
Philadelphia, PA USA-London UK (October 31, 2007)
Thomson Scientific,
part of The Thomson Corporation (NYSE: TOC; TSX:
TOC) and leading provider of information solutions
to the worldwide research and business communities,
today announced that it has added EMBASE® Classic
to the Dialog® (File 772) and DataStar® (EM73,
EMXX) platforms, providing access to more than
25 years of archived life sciences data available
for the first time in electronic format. For more
information about the EMBASE Classic database on Dialog and DataStar,
visit www.dialog.com/embaseclassic.
EMBASE Classic, produced by Elsevier, includes
the bibliographic records originally published in
the 43 Excerpta Medica abstract print journals
from 1947 through 1973. The fully digitized database
is drawn from approximately 3,400 international journal
titles, with a focus on European and North American
published literature including non-English language
articles. EMBASE Classic contains more than 1.8 million
records from the biomedical and pharmacological literature.
The historical data in EMBASE Classic, combined with
up-to-date records in the EMBASE database (File 73/EMZZ),
gives researchers approximately 60 years of information
regarding medical and drug-related subjects.
“With EMBASE Classic, researchers can now
review advancements made during an extremely fertile
period for the sciences, particularly in the areas
of molecular biology, marine sciences, vaccines and
other drug therapies,” said Geoffrey Dick,
Director of Publisher Management, Thomson Scientific. “The
archived literature should prove invaluable in reviews
of toxicology, adverse events and prior art for patent
prosecution.”
EMBASE Classic enhances research in:
- Drug development
- Pipeline intelligence
- Designing and mounting clinical investigations
- New uses for old drugs
- Approved uses for drugs
- Adverse events and reactions monitoring on old
drugs or endogenous compounds
- Preparation of new drug applications
- Product safety and compliance monitoring
EMBASE Classic significantly expands the collection
of biomedical and pharmacological literature sought
by research professionals. The new database complements
current Dialog and DataStar life
sciences offerings, including EMBASE® (1974+
in File 73/EMZZ), as well as the recently added BIOSIS
Previews® (File 5/BIOL), Zoological Record Online® and
MEDLINE (1951+ in File 155/MEZZ) archive data.
About The Thomson Corporation
The Thomson Corporation (www.thomson.com)
is a global leader in providing essential electronic
workflow solutions to business and professional customers. With
operational headquarters in Stamford, Conn., Thomson
provides value-added information, software tools
and applications to professionals in the fields of
law, tax, accounting, financial services, scientific
research and healthcare. The Corporation's
common shares are listed on the New York and Toronto
stock exchanges (NYSE: TOC; TSX: TOC).
Thomson Scientific is a business of The Thomson
Corporation. Its information solutions assist professionals
at every stage of research and development—from
discovery to analysis to product development and
distribution. Thomson Scientific information solutions
can be found at scientific.thomson.com.
top
| 
